Shareholder Alert: Ademi LLP investigates whether Augmedix, Inc. has obtained a Fair Price for its Public Shareholders

MILWAUKEE, July 19, 2024 /PRNewswire/ — Ademi LLP is investigating Augmedix (Nasdaq: AUGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Commure.

Click here to learn how to join our investigation https://www.ademilaw.com/case/augmedix-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Augmedix stockholders will receive only $2.35 per share in an all-cash transaction that values Augmedix at approximately $139 million in equity value. The transaction agreement unreasonably limits competing transactions for Augmedix by imposing a significant penalty if Augmedix accepts a competing bid. Augmedix insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Augmedix’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Augmedix common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/augmedix-inc.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

View original content:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-augmedix-inc-has-obtained-a-fair-price-for-its-public-shareholders-302201404.html

SOURCE Ademi LLP